Aldeyra Therapeutics

1 follower


Aldeyra Therapeutics develops treatments for aldehyde toxicity-related diseases including Sjögren-Larsson Syndrome (SLS) and noninfectious anterior uveitis.

Industries

Headquarters

Stage

Employees

Links

Todd C. Brady
CEO & President

Todd C. Brady

Collapse
Christopher Pearson
Vice President, Commercial Development and Strategy
David B. McMullin
Chief Commercial Officer
David J. Clark
Chief Medical Officer
David Noskowitz
Vice President, Regulatory Affairs
Lise L. Kjems
Vice President, Clinical Development
Stephen G. Machatha
Senior Vice President, Technical Operations
Bruce Greenberg
Senior Vice President Of Finance, Interim Cfo, And Treasurer